1Pujol F H,Devesa M.Genotypic variabillity of hepatitis viruses associated with chronic IFN ection and the development of hepatocellular carcinoma[J].J Clin Gastroenterol,2005,39 (7):611-618.
3Torresi J,Locarmini S.Antiviral chemotherapy for the treatment of hepatitis B virus IFNection[J].Gastroenterology,2000,118:83-103.
4Buti M,Esteban R.Drugs in development for hepatitis B[J].Drugs,2005,65(11):1451-1460.
5Scott K F,Anna S F.Drug insight:nucleoside and nucleotide analog inhibitors for hepatitis B[J].Gastroenterology & Hepatology,2004,1 (2):90-97.
6Fung S K,Lok A S.Treatment of chronic hepatitis B:who to treat,what to use,and for how long?[J].Clin Gastroenterol Hepatol,2004,2 (10):839-948.
7Kunzi M S,Pitha P M.Interferon research:a brief history[J].Methods Mol Med,2005,116:25-35.
8Raquel M,Gregorio G,Inmaculada F,et al.A pilot study of β-interferon for treatment of patients with chronic hepatitis B who failed to respond to α-interferon[J].J Hepatology,2002,37:655-659.
9Tadatsugu T,Akinori T.The interferon-α/β system in antiviral responses:a multimodal machinery of gene regulation by the IRF family of transcription factors[J].Current Opinion Immunology,2002,14:111-116.
